Clinical Trials · NCT07218445
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 40
- Start date
- Apr 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in Vasomotor Symptoms Frequency